| 2 | Microvascular Adaptations to Exercise: Protective Effect of PGC-1 Alpha. (Kadlec AO, Barnes C, Durand MJ, Gutterman DD) Am J Hypertens 2018 Jan 12;31(2):240-246 8 Citations |
| 1 | Effect of diltiazem on exercise capacity after heart transplantation. (Varnado S, Peled-Potashnik Y, Huntsberry A, Lowes BD, Zolty R, Burdorf A, Lyden ER, Moulton MJ, Um JY, Raichlin E) Clin Transplant 2017 Aug;31(8) 4 Citations |
| 1 | Expert consensus guidelines: Anomalous aortic origin of a coronary artery. (Brothers JA, Frommelt MA, Jaquiss RDB, Myerburg RJ, Fraser CD Jr, Tweddell JS) J Thorac Cardiovasc Surg 2017 Jun;153(6):1440-1457 308 Citations |
| 1 | Introduction. (Patel PJ) Tech Vasc Interv Radiol 2016 Jun;19(2):89-90 |
| 1 | Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease. (Ait-Aissa K, Ebben JD, Kadlec AO, Beyer AM) Pharmacol Res 2016 Sep;111:422-433 31 Citations |
| 1 | Consensus review of the treatment of cardiovascular disease in people with hemophilia A and B. (Ferraris VA, Boral LI, Cohen AJ, Smyth SS, White GC 2nd) Cardiol Rev 2015;23(2):53-68 63 Citations |
| 2 | Safety of Enteral Feedings in Critically Ill Children Receiving Vasoactive Agents. (Panchal AK, Manzi J, Connolly S, Christensen M, Wakeham M, Goday PS, Mikhailov TA) JPEN J Parenter Enteral Nutr 2016 Feb;40(2):236-41 63 Citations |
| 1 | Optimizing drug therapy in the surgical intensive care unit. (Peppard WJ, Peppard SR, Somberg L) Surg Clin North Am 2012 Dec;92(6):1573-620 4 Citations |
| 1 | Protection from myocardial ischemia/reperfusion injury by a positive allosteric modulator of the A₃ adenosine receptor. (Du L, Gao ZG, Nithipatikom K, Ijzerman AP, Veldhoven JP, Jacobson KA, Gross GJ, Auchampach JA) J Pharmacol Exp Ther 2012 Jan;340(1):210-7 33 Citations |
| 1 | Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial. (Brilakis ES, Lichtenwalter C, Abdel-karim AR, de Lemos JA, Obel O, Addo T, Roesle M, Haagen D, Rangan BV, Saeed B, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S) JACC Cardiovasc Interv 2011 Feb;4(2):176-82 106 Citations |
| 1 | Effects of magnesium on central arterial compliance in preeclampsia. (Rogers DT, Colon M, Gambala C, Wilkins I, Hibbard JU) Am J Obstet Gynecol 2010 May;202(5):448.e1-8 14 Citations |
| 2 | Percutaneous revascularization of chronic total occlusions. (Patel PJ, Hieb RA, Bhat AP) Tech Vasc Interv Radiol 2010 Mar;13(1):23-36 12 Citations |
| 1 | Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial. (Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Holper EM, Haagen D, Saeed B, Iturbe JM, Shunk K, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S, Brilakis ES) JACC Cardiovasc Interv 2009 Sep;2(9):855-60 47 Citations |
| 1 | The immediate impact of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial on the management of stable angina. (Atwater BD, Oujiri J, Wolff MR) Clin Cardiol 2009 Aug;32(8):E1-3 12 Citations |
| 1 | What's new in clinical pharmacology and therapeutics. (Chawla PS, Kochar MS) WMJ 2008 Apr;107(2):76-83 |
| 1 | A novel use of the implantable ventricular assist device for isolated right heart failure. (Osaki S, Edwards NM, Johnson MR, Kohmoto T) Interact Cardiovasc Thorac Surg 2008 Aug;7(4):651-3 8 Citations |
| 1 | Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart. (Gross GJ, Gauthier KM, Moore J, Falck JR, Hammock BD, Campbell WB, Nithipatikom K) Am J Physiol Heart Circ Physiol 2008 Jun;294(6):H2838-44 84 Citations |
| 1 | Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease. (Ramana RK, Ronan A, Cohoon K, Homan D, Sutherland J, Steen L, Liu J, Loeb H, Lewis BE) Catheter Cardiovasc Interv 2008 Jun 01;71(7):886-93 38 Citations |
| 1 | Preconditioning of the myocardium by volatile anesthetics. (Kwok WM, Aizawa K) Curr Med Chem Cardiovasc Hematol Agents 2004 Jul;2(3):249-55 9 Citations |
| 1 | Chronic AT(1) receptor blockade alters mechanisms mediating responses to hypoxia in rat skeletal muscle resistance arteries. (Phillips SA, Drenjancevic-Peric I, Frisbee JC, Lombard JH) Am J Physiol Heart Circ Physiol 2004 Aug;287(2):H545-52 15 Citations |
| 1 | Racial differences in adherence to cardiac medications. (Charles H, Good CB, Hanusa BH, Chang CC, Whittle J) J Natl Med Assoc 2003 Jan;95(1):17-27 102 Citations |
| 1 | Contribution of cytochrome P-450 omega-hydroxylase to altered arteriolar reactivity with high-salt diet and hypertension. (Frisbee JC, Falck JR, Lombard JH) Am J Physiol Heart Circ Physiol 2000 May;278(5):H1517-26 58 Citations |
| 1 | Impaired endothelial function in transgenic mice expressing both human renin and human angiotensinogen. (Didion SP, Sigmund CD, Faraci FM) Stroke 2000 Mar;31(3):760-4; discussion 765 54 Citations |
| 1 | Antiarrhythmic action of the new calcium antagonist [1,2,5-trimethyl-4-phenyl-4-beta-(N-cyanoethyl-N-4'-methoxybenzyl) -ethylamino]piperidine dihydrochloride. (Alexanian AR, Arutyunian NS, Galoyan AA) Arzneimittelforschung 1996 Dec;46(12):1110-3 3 Citations |
| 1 | Pancreatitis associated with remote traumatic brain injury in children. (Urban M, Splaingard M, Werlin SL) Childs Nerv Syst 1994 Aug;10(6):388-91 6 Citations |
| 1 | Zatebradine, a specific bradycardic agent, enhances the positive inotropic actions of dobutamine in ischemic myocardium. (Wynsen JC, O'Brien PD, Warltier DC) J Am Coll Cardiol 1994 Jan;23(1):233-41 14 Citations |
| 1 | Regional redistribution of myocardial perfusion by UL-FS 49, a selective bradycardic agent. (O'Brien P, Drage D, Saeian K, Brooks HL, Warltier DC) Am Heart J 1992 Mar;123(3):566-74 15 Citations |
| 1 | Selected vasoactive drugs: a readily available chart reference. (Whipple JK, Medicus-Bringa MA, Schimel BA, Jiricka MK, Lynch MC, Quebbeman EJ) Crit Care Nurse 1992 Mar;12(3):23-9 |
| 1 | Specific bradycardic agents, a new therapeutic modality for anesthesiology: hemodynamic effects of UL-FS 49 and propranolol in conscious and isoflurane-anesthetized dogs. (Riley DC, Gross GJ, Kampine JP, Warltier DC) Anesthesiology 1987 Nov;67(5):707-16 26 Citations |
| 1 | Efficacy of a programmed calculator for constant-infusion medication calculations. (Kelly KJ, Neu J, Rice TB, Crim W, Eisenberg C) Pediatrics 1984 Jan;73(1):68-70 7 Citations |
© 2026 Clinical & Translational Science Institute